Foghorn Therapeutics Inc.
FHTXNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $141.97M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.79$7.61
- Volume (live)
- -
- Avg. volume (3M)
- 1.11M
Foghorn Therapeutics (FHTX) Stock Price & Financial Analysis
Foghorn Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.99 - $2.09 |
|---|---|
| 52-Week High | $7.61 |
| 52-Week Low | $1.79 |
| Open | $2.00 |
| Volume (last close) | 301.05K |
| Average Volume (3M) | 1.11M |
| Revenue (TTM) | 36.74M |
|---|---|
| Net Income (TTM) | -64.58M |
| Free Cash Flow (TTM) | -84.29M |
| EPS (TTM) | −$0.97 |
| Profit Margin | -175.78% |
| Operating Margin | -186.38% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 141.97M |
|---|---|
| Shares Outstanding | 70.63M |
| Price to Sales (P/S) | 3.86 |
| Price to Book (P/B) | -1.75 |
| EV/EBITDA | -1.75 |
| 50-Day MA | $4.35 |
|---|---|
| 200-Day MA | $4.85 |
| 1-Year Change | −48.46% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Foghorn Therapeutics at a Glance
As of the Oct 22, 2026 close, Foghorn Therapeutics (FHTX) has a market capitalization of $141.97M. The stock trades at 3.9× sales. Over the trailing twelve months it lost $64.58M on revenue of $36.74M and burned $84.29M of free cash flow. Revenue grew 52.0% year over year.
As of its latest reported balance sheet, it holds $68.08M in cash and securities against $43.10M of debt, a net cash position of $24.98M.
Foghorn Therapeutics does not currently pay a dividend.
The share price is down 48.5% over the past year. At $2.01 (the Oct 22, 2026 close) it sits near the bottom of its 52-week range of $1.79 to $7.61, below its 200-day moving average of $4.85.
Based on 11 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.29, 212.9% above the Oct 22, 2026 close.
Frequently Asked Questions About Foghorn Therapeutics
What is the current stock price for FHTX?
As of the Oct 22, 2026 close, FHTX stock trades at $2.01. The 52-week range is $1.79–$7.61, with a day range of $1.99–$2.09.
What is the P/E ratio for FHTX?
The P/E ratio (Price-to-Earnings) for FHTX is shown in the Key Statistics section. This valuation metric helps compare Foghorn Therapeutics Inc. to industry peers.
Does FHTX pay dividends?
Foghorn Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FHTX?
Based on ratings from 11 professional analysts over the last 90 days, the consensus for FHTX is Buy. The average 12-month price target is $6.29, a 212.9% upside from the Oct 22, 2026 close of $2.01.
What is the market cap of FHTX?
As of the Oct 22, 2026 close, Foghorn Therapeutics's market capitalization is $142.0M, classifying it as a micro-cap company. Foghorn Therapeutics operates in the Healthcare sector within the Biotechnology industry.